Literature DB >> 23333624

The autoimmune-predisposing variant of lymphoid tyrosine phosphatase favors T helper 1 responses.

Torkel Vang1, Johannes Landskron, Marte K Viken, Nikolaus Oberprieler, Knut M Torgersen, Tomas Mustelin, Kjetil Tasken, Lutz Tautz, Robert C Rickert, Benedicte A Lie.   

Abstract

The C1858T single nucleotide polymorphism in PTPN22, which is the gene encoding lymphoid tyrosine phosphatase (LYP), confers increased risk for various autoimmune disorders in Caucasians. Although the disease-associated LYP allele (LYP*W620) is a gain-of-function variant that has higher catalytic activity than the major allele (LYP*R620), it is still unclear how LYP*W620 predisposes for autoimmunity. Here, we compared both T cell signaling and T cell function in healthy human donors homozygous for either LYP*R620 or LYP*W620. Generally, the presence of LYP*W620 caused reduced proximal T cell antigen receptor-mediated signaling (e.g. ζ chain phosphorylation) but augmented CD28-associated signaling (e.g. AKT activation). Altered ligand binding properties of the two LYP variants could explain these findings since LYP*R620 interacted more strongly with the p85 subunit of PI3K. Variation in signaling between cells expressing either LYP*R620 or LYP*W620 also affected the differentiation of conventional CD4(+) T cells. For example, LYP*W620 homozygous donors displayed exaggerated Th1 responses (e.g. IFNγ production) and reduced Th17 responses (e.g. IL-17 production). Importantly, while regulatory T cells normally suppressed Th1-mediated IFNγ production in LYP*R620 homozygous individuals, such suppression was lost in LYP*W620 homozygous individuals. Altogether, these findings provide a molecular and cellular explanation for the autoimmune phenotype associated with LYP*W620.
Copyright © 2013 American Society for Histocompatibility and Immunogenetics. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23333624      PMCID: PMC4011173          DOI: 10.1016/j.humimm.2012.12.017

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  27 in total

1.  Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue.

Authors:  Edoardo Fiorillo; Valeria Orrú; Stephanie M Stanford; Yingge Liu; Mogjiborahman Salek; Novella Rapini; Aaron D Schenone; Patrizia Saccucci; Lucia G Delogu; Federica Angelini; Maria Luisa Manca Bitti; Christian Schmedt; Andrew C Chan; Oreste Acuto; Nunzio Bottini
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

2.  Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells.

Authors:  Weiming Ouyang; Omar Beckett; Qian Ma; Ji-hye Paik; Ronald A DePinho; Ming O Li
Journal:  Nat Immunol       Date:  2010-05-13       Impact factor: 25.606

3.  Association of PTPN22 gene functional variants with development of pulmonary tuberculosis in Moroccan population.

Authors:  H Lamsyah; B Rueda; L Baassi; R Elaouad; N Bottini; K Sadki; J Martin
Journal:  Tissue Antigens       Date:  2009-06-25

4.  B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression.

Authors:  Jonathan M Irish; June H Myklebust; Ash A Alizadeh; Roch Houot; Jeff P Sharman; Debra K Czerwinski; Garry P Nolan; Ronald Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-11       Impact factor: 11.205

5.  Foxo transcription factors control regulatory T cell development and function.

Authors:  Yann M Kerdiles; Erica L Stone; Daniel R Beisner; Daniel L Beisner; Maureen A McGargill; Irene L Ch'en; Christian Stockmann; Carol D Katayama; Stephen M Hedrick
Journal:  Immunity       Date:  2010-12-14       Impact factor: 31.745

6.  High-resolution mapping of prostaglandin E2-dependent signaling networks identifies a constitutively active PKA signaling node in CD8+CD45RO+ T cells.

Authors:  Nikolaus G Oberprieler; Simone Lemeer; Maria E Kalland; Knut M Torgersen; Albert J R Heck; Kjetil Taskén
Journal:  Blood       Date:  2010-06-17       Impact factor: 22.113

7.  PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background.

Authors:  Julie Zikherman; Michelle Hermiston; David Steiner; Kiminori Hasegawa; Andrew Chan; Arthur Weiss
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

8.  Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells.

Authors:  Christian Becker; Christian Taube; Tobias Bopp; Christoph Becker; Kai Michel; Jan Kubach; Sebastian Reuter; Nina Dehzad; Markus F Neurath; Kurt Reifenberg; Franz-Joseph Schneider; Edgar Schmitt; Helmut Jonuleit
Journal:  Blood       Date:  2009-05-13       Impact factor: 22.113

Review 9.  Recent advances in the genetics of autoimmune disease.

Authors:  Peter K Gregersen; Lina M Olsson
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

10.  Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells.

Authors:  Yohsuke Harada; Yasuyo Harada; Chris Elly; Ge Ying; Ji-Hye Paik; Ronald A DePinho; Yun-Cai Liu
Journal:  J Exp Med       Date:  2010-05-03       Impact factor: 14.307

View more
  28 in total

Review 1.  The Contribution of PTPN22 to Rheumatic Disease.

Authors:  Tomas Mustelin; Nunzio Bottini; Stephanie M Stanford
Journal:  Arthritis Rheumatol       Date:  2019-03-02       Impact factor: 10.995

2.  PTPN22 1858C>T polymorphism is associated with increased CD154 expression and higher CD4+ T cells percentage in rheumatoid arthritis patients.

Authors:  Yeniley Ruiz-Noa; Jorge Hernández-Bello; Mara A Llamas-Covarrubias; Claudia A Palafox-Sánchez; Edith Oregon-Romero; Pedro Ernesto Sánchez-Hernández; Maria Guadalupe Ramírez-Dueñas; Isela Parra-Rojas; Jose Francisco Muñoz-Valle
Journal:  J Clin Lab Anal       Date:  2018-11-06       Impact factor: 2.352

Review 3.  PTPN22: the archetypal non-HLA autoimmunity gene.

Authors:  Stephanie M Stanford; Nunzio Bottini
Journal:  Nat Rev Rheumatol       Date:  2014-07-08       Impact factor: 20.543

Review 4.  Regulation of autoimmune and anti-tumour T-cell responses by PTPN22.

Authors:  Rebecca J Brownlie; Rose Zamoyska; Robert J Salmond
Journal:  Immunology       Date:  2018-04-16       Impact factor: 7.397

5.  PTPN22 contributes to exhaustion of T lymphocytes during chronic viral infection.

Authors:  Christian J Maine; John R Teijaro; Kristi Marquardt; Linda A Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-31       Impact factor: 11.205

6.  The protein tyrosine phosphatase PTPN22 controls forkhead box protein 3 T regulatory cell induction but is dispensable for T helper type 1 cell polarization.

Authors:  G Fousteri; T Jofra; I Debernardis; S M Stanford; A Laurenzi; N Bottini; M Battaglia
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

Review 7.  Genetics of Lupus Nephritis: Clinical Implications.

Authors:  Melissa E Munroe; Judith A James
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

Review 8.  Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease.

Authors:  Nunzio Bottini; Erik J Peterson
Journal:  Annu Rev Immunol       Date:  2013-12-18       Impact factor: 28.527

Review 9.  Obstacles and opportunities for targeting the effector T cell response in type 1 diabetes.

Authors:  Jane H Buckner; Gerald T Nepom
Journal:  J Autoimmun       Date:  2016-03-03       Impact factor: 7.094

10.  Autoimmune Variant PTPN22 C1858T Is Associated With Impaired Responses to Influenza Vaccination.

Authors:  Juliet N Crabtree; Wenqian He; Weihua Guan; Mark Flage; Matthew S Miller; Erik J Peterson
Journal:  J Infect Dis       Date:  2016-03-30       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.